Deal Details

Ad-Tech Is Acquired by Nihon Kohden

---

Summary

About

Founded in Greater Milwaukee in 1983, Ad-Tech is the world’s leading manufacturer of intracranial neuro electrodes. Ad-Tech’s minimally invasive devices provide brain mapping used in the diagnostics and treatment of a wide range of disorders, including epilepsy. Ad-Tech products are approved for use in more than 60 countries and have a strong reputation among the neurosurgical community. Ad-Tech is headquartered in Oak Creek, Wisconsin.

With offices in Europe, North America and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include MedTech, Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation. ARCHIMED is headquartered in Lyon, France.

Founded in Japan in 1951, Nihon Kohden is a leading manufacturer, developer and distributor of medical electronic equipment, with subsidiaries in the U.S., Europe, Asia and Latin America. Nihon Koden's products are now used in more than 120 countries, and it is the largest supplier of electroencephalography products worldwide. A pioneer in transformational healthcare technology, Nihon Kohden has envisioned, designed and produced revolutionary devices, such as pulse oximeters, arrhythmia analysis, low-invasive blood volume monitoring and wireless patient monitoring. Nihon Kohden is headquartered in Tokyo, Japan.

---

CONTACT US TO LEARN MORE